Sibling Oocyte Study of Medium for In Vitro Fertilization/Intracytoplasmic Sperm Injection (IVF/ICSI) With no Human Serum Albumine

Phase 2

Withdrawn

• Conditions: Infertility; In Vitro Fertilization

• Registration Number: NCT00541892
• Lead Sponsor: Sykehuset Telemark

Brief Summary

The purpose of this study is to determine if a new medium with no human serum albumine added is as good as the media conventionally used for IVF/ICSI.

Detailed Description

Cells attained in IVF/ICSI procedures are kept in a medium that nurture the cells. Until now all such media have contained human serum albumine. The purpose of this study is to determine if a new medium with no human serum albumine added is as good as the media conventionally used for IVF/ICSI.

Study Timeline

• Study Start: 2007-09
• Study First Submitted: 2007-10-09
• Study First Submitted QC: 2007-10-09
• Study First Posted: 2007-10-10
• Primary Completion: 2014-01
• Study Completion: 2014-01
• Status Verified: 2015-05
• Last Update Submitted: 2015-05-19
• Last Update Posted: 2015-05-20

Recruitment & Eligibility

• Status: WITHDRAWN
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

• Couples seeking IVF/ICSI.
• Female under 38 years of age.
• No more than two previous IVF/ICSI treatments without pregnancy.
• Regular menstruation periods.
• No endocrine disease that requires treatment in the female.
• BMI below 30 in the female.
• At least 8 mature follicles upon monitoring or 6 MII oocytes upon ICSI.
• Written informed consent.

Exclusion Criteria

• Low responders to FSH.
• Females in danger of developing OHSS.
• Sperm sample below ICSI-quality.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Fertilization	24 hours
Cleavage	48 hours
Embryo score	48 hours
Embryos used	48 hours

Trial Locations

Locations (1)

Fertilitetsklinikken Sør; 🇳🇴 Porsgrunn, Telemark, Norway